11.2 Capital
11.2 Capital invests in founders solving the biggest challenges facing our world with emerging technologies. They focus on emerging technologies and believe great people are leading indicators of a company's success. The firm provides resources to entrepreneurs, including technical recruiting and partnerships.
Offices: San Francisco (United States)
Investment Stages: Seed, Series A, Series B
Markets: AI, cybersecurity, quantum, robotics, new space, data-driven healthcare, climate tech
Founded Year: 2014
Investor Type: Venture Capital
Portfolio Companies: TigerGraph, WhiteOps, Avaamo, Ginkgo Bioworks, Forter, Auransa, Caption Health, Cruise Automation, Placenote, Notable Labs, Savioke, Molecular Assemblies, Kindred, Deep Genomics, Lucira Health, Loop Genomics, Hinge Health, Mason, Genturi, Bytegain, Passage AI, Mantle, AEVA, Synthace, KOKO, Covariant AI, Outlier, CryptoNumerics, Anyscale, Endear, Elucidate, Sardine, uMed, JupiterOne, Matchwell, StrikeReady, Kolena, Coalesce, Permiso, MightyMeld, Surf Security
Website: https://www.112capital.com
Portfolio Link: http://www.112capital.com/companies.html
LinkedIn: https://www.linkedin.com/company/eleven-two-capital
Crunchbase: https://www.crunchbase.com/organization/112capital
Comments
No comments yet. Be the first to comment!